“Rapid and sustained improvements in itch and sleep with tralokinumab treatment in patients with moderate-to-severe Atopic Dermatitis, a post hoc analysis of pooled data from ECZTRA 1 and 2” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s61. doi:10.25251/skin.5.supp.61.